C

    Champions Oncology Inc (CSBR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.00
    +0.07 (+1.32%)

    Market Cap: $68.50M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    53%(17/32)
    Avg Surprise
    +84.01%
    Streak
    1 Q
    PeriodReportedEst.SurpriseB/MYoY
    Apr 26
    		$-0.05$-0.05+0.00%Beat+28.6%
    Jan 26
    		$-0.02N/A-125.13%Miss-106.1%
    Oct 25
    		$0.06$0.01+500.00%Beat+20.0%
    Jul 25
    		$0.02$-0.01+300.00%Beat-81.8%
    Apr 25
    		$-0.07$0.06-216.67%Miss-800.0%
    Jan 25
    		$0.33$-0.01+3400.00%Beat+306.3%
    Oct 24
    		$0.05$0.01+400.00%Beat+133.3%
    Jul 24
    		$0.11$-0.03+466.67%Beat+168.8%
    Apr 24
    		$0.01N/A+106.25%Beat+105.3%
    Jan 24
    		$-0.16$-0.06-166.67%Miss+0.0%
    Oct 23
    		$-0.15$-0.16+6.25%Beat-1600.0%
    Jul 23
    		$-0.16$-0.10-60.00%Miss-1500.0%
    Apr 23
    		$-0.19$-0.12-58.33%Miss-533.3%
    Jan 23
    		$-0.16$-0.01-1500.00%Miss-328.6%
    Oct 22
    		$0.01$0.02-50.00%Miss-66.7%
    Jul 22
    		$-0.01$0.02-150.00%Miss-200.0%
    Apr 22
    		$-0.03$0.03-200.00%Miss+25.0%
    Jan 22
    		$0.07$0.04+75.00%Beat+0.0%
    Oct 21
    		$0.03$0.02+50.00%Beat+29900.0%
    Jul 21
    		$0.01$0.01+0.00%Beat+0.0%
    Apr 21
    		$-0.04$0.00N/ABeat+71.4%
    Jan 21
    		$0.07$0.01+600.00%Beat+40.0%
    Oct 20
    		$0.00N/A-99.00%Miss-99.7%
    Jul 20
    		$0.01N/A+133.33%Beat+120.0%
    Apr 20
    		$-0.14$0.02-800.00%Miss-1300.0%
    Jan 20
    		$0.05$0.03+66.67%Beat+400.0%
    Oct 19
    		$0.03$0.01+200.00%Beat+0.0%
    Jul 19
    		$-0.05$0.02-350.00%Miss-200.0%
    Apr 19
    		$-0.01N/A-133.33%Miss+75.0%
    Jan 19
    		$0.01N/A-66.67%Miss+200.0%
    Oct 18
    		$0.03$0.05-40.00%Miss+400.0%
    Jul 18
    		$0.05$0.01+400.00%Beat+183.3%
    Apr 18
    		$-0.04$-0.04+0.00%Beat+73.3%
    Jan 18
    		$-0.01N/AN/ABeat+90.9%
    Oct 17
    		$-0.01N/AN/ABeat+78.3%
    Jul 17
    		$-0.06N/AN/ABeat-
    Apr 17
    		$-0.15N/AN/ABeat-
    Jan 17
    		$-0.11N/AN/ABeat-
    Oct 16
    		$-0.05N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio504.55EV/EBITDA199.38x
    Price/FCF-13.77xFCF Yield-7.26%
    Profitability
    Profit Margin-1.98%Operating Margin-3.77%
    ROE-30.00%ROIC-39.78%
    Financial Health
    Debt/Equity0.38xInterest CoverageN/A
    Current Ratio0.98xQuick Ratio0.98x
    Trading Statistics
    Beta0.41Avg Volume9.31K
    52-Week High$8.7452-Week Low$4.83

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.00
    SMA 20$5.07
    SMA 50$5.59
    SMA 200$6.12
    EMA 10$5.01
    EMA 20$5.13
    EMA 50$5.45
    EMA 200$6.11

    MACD

    Line: -0.18Signal: -0.20Hist: 0.02

    ADX

    ADX: 22.9+DI: 15.2-DI: 19.4

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down72.0
    PSAR$5.27

    Bollinger Bands

    Upper Band$5.35
    Lower Band$4.79
    %B Position1091%(Upper)
    Band Width0.37

    RSI (14-Day)

    Neutral
    42.1

    Momentum Oscillators

    Stoch %K28.2
    Stoch %D25.4
    Williams %R-67.3
    ROC (10d)-0.7%
    Momentum-0.04
    CCI (20d)-58.4
    MFI (14d)61.0

    Volatility Measures

    ATR (14d)$0.25(5.0%)
    StdDev (20d)0.14
    Hist Vol38.5%(Moderate)

    Volume Flow

    VWAP$4.99
    OBV-726.1K
    AD Line-909.0K
    CMF (20d)-0.252

    Volume Metrics

    Avg Vol (20d)9.6K
    Vol Ratio0.1x(Low)
    VWMA (20d)$5.11

    Pivot Points

    R3$5.21
    R2$5.16
    R1$5.04
    Pivot Point$4.99
    S1$4.87
    S2$4.82
    S3$4.70

    Advanced Oscillators

    TSI-21.16
    Ultimate Osc43.3
    KST-118.42

    Financial Data

    QuarterJan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023Jul 2023Apr 2023
    Total Revenue$16.56M$15.04M$13.99M$12.36M$17.04M$13.49M$14.06M$14.00M$12.02M$11.57M$12.56M$13.07M
    Cost of Revenue$8.83M$7.26M$8.00M$7.27M$6.62M$7.43M$7.07M$7.25M$7.85M$6.62M$7.68M$7.34M
    Gross Profit$7.72M$7.77M$6.00M$5.08M$10.42M$6.06M$6.99M$6.75M$4.17M$4.96M$4.88M$5.73M
    Operating Expenses$8.00M$7.59M$6.53M$7.09M$5.92M$5.33M$5.66M$7.02M$6.75M$6.91M$7.43M$8.25M
    R&D$2.27M$2.62M$2.08M$1.96M$1.72M$1.69M$1.45M$2.05M$2.19M$2.52M$2.79M$2.85M
    SG&A$2.98M$2.97M$2.57M$2.52M$2.40M$1.89M$2.53M$2.76M$2.76M$2.60M$2.94M$2.75M
    Operating Income$-276,000$185,000$-527,000$-2,007,000$4.50M$732,000$1.33M$-272,000$-2,577,000$-1,955,000$-2,552,000$-2,521,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$105,000$0$20,000
    Income Before Tax$-237,000$255,000$-452,000$-1,965,000$4.52M$739,000$1.33M$-191,000$-2,519,000$-2,060,000$-2,538,000$-2,541,000
    Income Tax Expense$42,000$18,000$14,000$-130,000$23,000$11,000$21,000$-82,000$11,000$11,000$28,000$20,000
    Net Income$-279,000$237,000$-466,000$-1,835,000$4.50M$728,000$1.31M$-109,000$-2,530,000$-2,071,000$-2,566,000$-2,561,000
    EBITDA$104,000$612,000$-94,000$-1,571,000$4.92M$1.14M$1.78M$266,000$-2,038,000$-1,576,000$-2,093,000$-1,958,000
    EBIT$-237,000$255,000$-452,000$-1,965,000$4.52M$739,000$1.33M$-191,000$-2,519,000$-2,060,000$-2,538,000$-2,541,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CSBR

    News

    Precision Trading with Champions Oncology Inc. (CSBR) Risk Zones

    This article provides an AI-driven analysis of Champions Oncology Inc. (CSBR) for precision trading, indicating weak sentiment across all time horizons which supports a short bias. It outlines three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry points, targets, and stop losses. The analysis also includes multi-timeframe signal strengths, support, and resistance levels for near-term, mid-term, and long-term perspectives.

    Stock Traders Daily•8/16/26•
    Bearish

    Champions Oncology Inc (CSBR) Earnings Forecast: Future EPS & Revenue Growth Estimates

    This article provides an earnings forecast for Champions Oncology Inc (CSBR), noting that no earnings forecast score is currently available, but the industry average is 8.10. Analysts have set a consistent price target of $12.00, with an upside potential of over 109%. The report also includes expected revenue for the next quarter and past/future EPS performance.

    TradingKey•8/7/26•
    Bullish

    Champions Oncology (NASDAQ:CSBR) Stock Price Crosses Below 200 Day Moving Average - Here's Why

    Champions Oncology (NASDAQ:CSBR) saw its stock price fall below its 200-day moving average to $5.76, amidst a downgrade from Weiss Ratings to "sell (E+)." Despite beating quarterly earnings expectations with $0.01 EPS against an anticipated $0.05 loss and revenues of $13.84 million, the company still reported negative return on equity and net margin. Hedge funds have shown mixed activity, with some increasing and others initiating stakes in the biotechnology company.

    MarketBeat•8/4/26•
    Bearish

    Enterprise value to EBITDA forward of Champions Oncology, Inc. – NASDAQ:CSBR

    The article focuses on the "Enterprise value to EBITDA forward" financial metric for Champions Oncology, Inc. (NASDAQ: CSBR). It appears to be a financial data snippet or a specific metric page from TradingView, providing financial information for the company. The content lists various sections related to financial data, news, community, and technical analysis for CSBR.

    TradingView•8/1/26•
    Neutral

    Champions Oncology, Inc. Revenue Breakdown – NASDAQ:CSBR

    Champions Oncology, Inc. (NASDAQ: CSBR) generated $59.42 million in revenue last year, primarily from its Pharmacology Services segment, which contributed $57.13 million. The majority of this revenue, $59.42 million, came from operations within the United States. This represents an increase from the previous year's total revenue of $48.59 million.

    TradingView•8/1/26•
    Neutral

    Frequently Asked Questions About CSBR

    Does CSBR pay dividends?
    Champions Oncology Inc (CSBR) does not currently pay a regular dividend.
    What is CSBR's P/E ratio?
    Champions Oncology Inc has a price-to-earnings (P/E) ratio of 504.55.
    What is CSBR's market cap?
    Champions Oncology Inc (CSBR) has a market capitalization of $68.50M with a current stock price of $5.00.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In